Industry News


Japanese drug production grew in 2015 according to new MHLW data

12 April 2017 By Gareth MacDonald, Domestic Pharmaceutical production increased in Japan in 2015 according to data release by the MHLW. A study by the Ministry of Health,...

Japan’s Takeda acquires US cancer drug manufacturer ARIAD for $5.2bn

February 2017 By Pharmaceutical Technology Japan-based Takeda Pharmaceutical Company has completed the previously announced acquisition of American oncology company ARIAD Pharmaceuticals for $5.2bn...

Sanofi to launch 20 new drugs in Japan by 2020

29 November 2016 By BioSpectrum Bureau In Japan, Sanofi is eager to introduce new drugs as generics continue to eat its profits. Singapore: If reports are to be believed French drug giant Sanofi is...

‘Huge Sellers’ Herald Changes in Japan Drug Pricing

Oct 13, 2016 By Donald Macarthur, Pharmaceutical Executive, Volume 36, Issue 10 The revision of pricing rules that occurs every...
pic hodgkin lymphoma

Japan's Non-Hodgkin Lymphoma Market to Top $1 Billion by 2020

Sep 25, 2014 By The Pharm Exec staff Pharmaceutical Executive -- The Non-Hodgkin Lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia, China and Japan will expand...
Pic Tokyo Tower

Report from Japan

After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharma market is making a comeback.